Evidence map›Paper›PMID 32407392›Full record

ArticlePloS one2020

The utility of simple questions to evaluate cognitive impairment.

Yugaku Daté, Daisuke Sugiyama, Hajime Tabuchi, Naho Saito, Mika Konishi, Yoko Eguchi, Yuki Momota, Takahito Yoshizaki, Kyoko Mashima, Masaru Mimura and 2 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yugaku DatéDepartments of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Daisuke SugiyamaFaculty of Nursing and Medical Care Graduate School of Health Management, Keio University, Kanagawa, Japan.
Hajime TabuchiDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Naho SaitoDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Mika KonishiDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Yoko EguchiDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Yuki MomotaDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Takahito YoshizakiDepartments of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Kyoko MashimaDepartments of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Masaru MimuraDepartments of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Jin NakaharaDepartments of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Daisuke ItoDepartments of Neurology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.ORCID 0000-0002-4740-1675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAs the population of patients with cognitive decline grows, physicians and caregivers need brief screening tools. Comprehensive neurocognitive batteries require special training and time for evaluation. We focused on accessibility and compared the diagnostic power of several easy questions.

design"Attended With" (AW) and "Head-Turning Sign" (HTS) factors and participants' replies to following questions were recorded: "Do you feel that you have more difficulties in your daily life than you used to?", [no consciousness (C-) or consciousness+ (C+)], "Could you tell me about your daily pleasures or pastimes?" [no pleasure (P-) or pleasure + (P+)], "What are notable current/recent news/topics?" [no news (N-) or news+ (N+)].

settingThis took place in our Memory Clinic between May 2016 and July 2019.

participantsWe enrolled 162 consecutive cases (44 cognitive normal (CN), 55 amnestic mild cognitive impairment (aMCI), and 48 Alzheimer's disease (AD)). MEASUREMENTS: The sensitivity and specificity of each battery were calculated, and on account of those numbers, the population attributable risk percent % (PAR%) of (AW and HTS+), (C- and P-), (C- and N-), (P- and N-) as analysis of combination of questions, respectively, were calculated.

resultsAW had high sensitivity, 87.4, 95.8% (CN vs aMCI + AD, CN + aMCI vs AD) but the sensitivity of HTS was only 46.4, 57.7%, and HTS showed high specificity, 100.0, 71.8%. C- had high sensitivity, 80.6, 87.5%, whereas P- and N- had high specificity, both 83.9% in CN vs aMCI + AD, 88.1% and 75.9% in CN + aMCI vs AD, respectively. In combination analysis, the PAR% of (C- and N-) were as high as (AW and HTS+).

conclusionsThe combination of (C- and N-) is as powerful as (AW and HTS+) in screening AD. Our findings provide novel insights for screening utility of brief questions "Consciousness of Impairment" and "Recent News."

Indexed as

Activities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseCognitive DysfunctionCommunicationFemaleHumansMaleMental Status and Dementia TestsMiddle AgedRetrospective StudiesSensitivity and SpecificitySpeech

Identifiers

PMID32407392
PMCPMC7224527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.